Vietnam Pharmaceutical Operation Consulting
YCP excels in pharmaceutical operation consulting in Vietnam, guiding clients to success in the country's competitive pharmaceutical sector. With decades of experience, YCP offers insights and hands-on support across a wide range of services, leveraging a global perspective to enhance your business growth.
YCP in Numbers
As the demand for high-quality medicine surges in Vietnam’s pharmaceutical sector,
67%
of pharmaceutical companies reported capacity challenges in local production last year,* indicating optimizing operations is critical for growth in Vietnam’s evolving market.
Source: Vietnam Ministry of Health, 2024
YCP Pharmaceutical Operation Experts in Vietnam
Vietnam's pharmaceutical industry is experiencing a vibrant transformation, marked by significant advancements across the sector. As one of Asia's emerging markets, the country's commitment to healthcare improvements has accelerated growth in pharmaceutical operations.
YCP, backed by a team of global professionals with deep market insights, provides an exceptional pharmaceutical operation consulting service. Our comprehensive expertise has been pivotal for clients in overcoming market entry barriers, navigating growth, and addressing complex drug development challenges in Vietnam.
Trust YCP as your go-to pharmaceutical operation partner in Vietnam to help elevate your business to new heights. With a proven track record and expertise, we enable your company's success within Vietnam's thriving pharmaceutical environment.
Unlocking Potential: Your Path to Excellence with
Vietnam's Pharmaceutical Operation Professionals
Batch Process Optimization
Operations Diagnostics
Productivity Improvement
Batch Process Optimization
In Vietnam's vibrant pharmaceutical operation sector, YCP expertly enhances batch process optimization for lasting efficiency and growth, benefiting your business profoundly.
Productivity Improvement
With profound understanding in Vietnam's pharmaceutical operation, YCP enhances productivity through innovative solutions tailored to industry-specific challenges.
Operations Diagnostics
In the dynamic Vietnam pharmaceutical industry, YCP expertly optimizes operations to enhance efficiency, compliance, and productivity for industry leaders.
Our Services
Digital Transformation
YCP drives seamless digital transformation enabling cutting-edge operations for Vietnam's pharmaceuticals.
- Digital Roadmap & DX Strategy
- DX Maturity Assessment
- CIO/CDO Advisory & IT Organization Design
- System Architecture & IT Portfolio Management
- AI, RPA & Intelligent Process Automation
- Big Data & Analytics
- Data Governance & Digital Adoption
- Offshore Development Centre Set-up
Market Research
Decoding Vietnam's pharma market to optimize operation strategies for improved business outcomes.
- Market Landscape
- Market Size
- Industry Structure and Trend
- Competitive Benchmark
- Business Partner Search & Screening
- B2B/B2C Customer Survey
- Consumer Research
Marketing & Sales
Optimize market strategies and sales performance for Vietnam's pharmaceutical leaders.
- Branding & Brand Management
- Product & Portfolio Management
- Pricing
- Digital Marketing
- E-commerce
- Customer Experience
- Sales Channel Strategy
- Digital Sales
- Lead Generation and Nurturing
- Content Marketing
M&A, Transactions, and PMI
Optimize Vietnam's pharmaceutical operations through YCP's strategic M&A and PMI solutions.
- M&A Strategy & Deal Sourcing
- Buy-Side & Sell-Side Advisory
- Cross-border M&A Advisory
- Commercial Due Diligence & Valuation
- Divestiture & Carve-out Strategy
- Post-Merger Integration (PMI) & Value Creation
- Joint Venture
- Corporate Venture Capital & IPO
Operations
Drive operational efficiency by strategically optimizing end-to-end pharmaceutical processes in Vietnam.
- Project Management Office (PMO)
- Growth Strategy Implementation
- Operation Transformation
- Manufacturing
- Organization Design
Public Services
Leverage industry expertise to optimize Vietnam’s pharmaceutical operations with strategic insight.
- Economic Development
- Public Policy Development
- E-Governance
Strategy
Breaking barriers, YCP tunes Vietnam's pharmaceutical operations to drive efficient strategies.
- Corporate & Business Strategy
- Growth Strategy & Market Entry
- Business Plan & Mid-Term Management Plan
- Competitive Landscape & Value Chain Analysis
- New Business Development & Feasibility Study
- Strategic Partnership & Channel Strategy
- Organization Strategy & Change Management
- Enterprise & Asset Risk Management
- Strategy Execution Support & Business Turnaround
- Digital Strategy
Supply Chain Management
Navigating Vietnam’s pharmaceutical landscape, YCP innovates tailored supply chain strategies.
- Supply Chain
- Digital Supply Chain
- Procurement
- Logistics
Sustainability
YCP transforms pharmaceutical operations in Vietnam, streamlining processes for sustainable growth.
- Sustainability Strategy & Implementation
- Double Materiality
- Decarbonization & Net-Zero Strategy
- Climate Change Risks and Opportunities
- Sustainability Due Diligence
- Supply Chain Assessment
- ESG Reporting
- Investor Relations & Fundraising
- Organization & Governance Design
Navigating Pharmaceutical Operation Sector in Vietnam
Pharmaceutical Regulation Challenges Escalate
- In Vietnam, strict regulatory controls increase the time to market, with complex approval processes delaying drug launches by 9 to 12 months.
- Substantial investment in tech innovations and expediting regulatory patience are crucial to navigating these stringent intertwining controls effectively.
Infrastructure Limitation Only Add to the Bottleneck
- With less than 50% of rural areas having proper healthcare facilities, distribution logistics post challenges in reaching broad healthcare provision.
- Efficiency improvements and tech establishment, especially faster response digital logistics systems, aim to cover 80+% of rural sectors by 2025.
Rising Domestic Demand Openings in Typically Niche Markets
- Drug consumption in Vietnam shows wide-spanning uptakes and is projected to reach approximately $6.6 billion by 2024, up surpassing regional growth.
- Responding technologies optimally harness rising demands through narrowly brilliant enhanced productions delivering quality specialty medications falling atop savvy portfolios.
Confederation Across ASEAN Benefit Horizons
- Working ASEAN agreements show capacity-delay descent supportive across packaged inceptions maximized at 14.6% yearly growth.
- Regions familiarity refine successful brand credibility networks keeping wider opening enjoy lines family broader motives firmly supplant reaching robust returns.
Our Clients
We have worked with more than 2000 companies throughout various industries.
What Our Clients Say About Us
"The systematic and detailed approach adopted by the YCP team has helped to provide an in-depth analysis of the specific businesses in the country we are interested to enter. Their findings and recommendations have helped us gain a better understanding and make strategic decisions on our business expansion plan in this specific emerging country. I am therefore happy to recommend YCP as a reliable partner to any company requiring research and consulting capabilities in the medical areas. "
Channels Manager ASEAN
Boston Scientific Asia Pacific
"YCP made sure they had a thorough understanding of our business needs and objectives and focused on the key aspects of the Vietnam market that helped us with our market development strategies. Their analysis and recommendations provided us with clear insights into the decision of our strategic options. "
Managing Director Asia Pacific
Teva Pharma
Results Through Expertise: Case Studies
Learn how we help clients build and implement strategies
that drive sustainable growth in today’s complex business landscape.
Corporate Entity Restructuring Advisory and M&A Target Search
Client
Fortune 500 MNC leader in medical imaging
Area
Indonesia
Expertise Scope
Mergers & Acquisition PMO
Project Summary
Amid the parent company's restructuring, our client sought YCP's expertise in re-entry strategy and M&A target identification. With our in-depth analysis, we negotiated with two M&A targets for 100% acquisition, saving over EUR 100M in investments.
E-Commerce Website Development
Client
A Japanese medical equipment manufacturer
Area
Southeast Asia
Expertise Scope
Strategic Marketing
Project Summary
Our client needed support tapping into the Southeast Asian market and building an e-commerce channel. We created a market entry strategy in three countries, developed localised landing pages, and managed client campaigns to gain market access.
YCP in Media
Our Group CEO Yuki Ishida and Managing Partner Karambir Anand shared insights at the ASEAN–Japan Young Business Leaders’ Summit.
At the Asian Power Summit 2025, our Director Harika G. led a session on Asia’s evolving energy mix.
Singapore Business Review featured Karambir Anand on Singapore’s expanding solar capacity and energy challenges.
Publications
Policy Ambitions Versus Reality – The Current Energy Transition in Vietnam
Vietnam is rapidly transitioning its energy system as power demand rises alongside industrial growth. While the government targets net-zero emissions by 2050, infrastructure, regulatory, and financing gaps slow progress. LNG, wind, and energy storage are key levers in the transition from coal to a greener energy mix.
The Strategic Response of Vietnamese Enterprises Amid US-China Tensions: Market Diversification and Embracing ESG Compliance
Vietnam’s export-led growth faces rising pressure as U.S.–China trade tensions and tariff risks intensify. While China+1 has driven past gains, firms must adapt by diversifying export markets, leveraging FTAs, and strengthening ESG capabilities to remain competitive and resilient in a shifting global trade environment.
政策愿景与现实——越南当前的能源转型
随着工业增长推动电力需求上升，越南正加快推进能源体系转型。尽管政府提出到2050年实现净零排放的目标，但基础设施、监管和融资方面的不足仍制约着转型进程。液化天然气（LNG）、风能和储能是推动从煤炭向更绿色能源结构转型的关键抓手。
中美紧张局势下越南企业的战略应对：市场多元化与 ESG 合规
随着中美贸易紧张局势加剧以及关税风险上升，越南以出口为导向的增长模式正面临更大压力。尽管「China+1」战略曾推动阶段性增长，但企业需通过出口市场多元化、充分利用自由贸易协定（FTA），以及强化ESG能力，才能在不断变化的全球贸易环境中保持竞争力和韧性。
Meet Our Experts
Establish industry dominance with our experts and partners
Yuki Ishida
Managing Partner
Nationality: Japanese
Region Coverage:
Asia, North America
Past Experience:
Goldman Sachs
Pilar Dieter
Managing Partner
Nationality: American
Region Coverage:
Asia, North America
Past Experience:
Alaris Consulting
Shingo Kasumoto
Managing Partner
Nationality: Japanese
Region Coverage:
Asia
Past Experience:
P&G
Leon Cheng
Partner
Nationality: Chinese
Region Coverage:
Asia, North America, South America
Past Experience:
EAC, DHL
Mehdi Jaouadi
Partner
Nationality: French
Region Coverage:
Asia, Europe, South America
Past Experience:
METRO AG, L'Oréal
Yuichi Ota
Partner
Nationality: Japanese
Region Coverage:
Japan, China, Vietnam
Past Experience:
GE Healthcare
Laurent Fihey
Partner
Nationality: French
Region Coverage:
Europe, Asia, Middle East, Africa, North America, South America
Past Experience:
Arthur Andersen, Advancy
Chi Ly
Director
Nationality: Vietnamese
Region Coverage:
Asia
Past Experience:
KPMG, PwC
Karambir Anand
Managing Partner
Nationality: Indian
Region Coverage:
ASEAN, China, India, United States, Europe, Australia
Past Experience:
EY-Parthenon, McKinsey & Company
Mridul Karkara
Partner
Nationality: Indian
Region Coverage:
India, United States, Europe, Southeast Asia
Past Experience:
THB, Deloitte
YCP Group is the leading professional firm in Asia empowering excellence through diverse expertise:
- YCP
- YCP Auctus
- YCP Consus
Talk to Our Pharmaceutical Operation Experts
Arrange a session with our experts to explore how YCP can assist you in addressing your business challenges.
YCP Group is the leading professional firm in Asia empowering excellence through diverse expertise:
- YCP
- YCP Auctus
- YCP Consus
